Assessment of Survival and Autonomy With Rituximab Plus Chemotherapy or Rituximab Plus Lenalidomide for Elderly Patients With Relapsed Diffuse Large B-cell Lymphoma
Clinical trial NCT04113226 · COMPLETED
Trial details
- NCT number
- NCT04113226
- Sponsor
- Centre Hospitalier Universitaire, Amiens
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-09
- Primary completion
- 2024-06-04
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.